Medicure Inc V.MPH

Alternate Symbol(s): MCUJF

Healthcare Biotechnology

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. It also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. It also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.

TSXV:MPH - Post by User

Medicure Inc > Someone tell me the odds are not in our favor.

<< Previous

Bullboard Posts

Next >>

Post by Checkouton Jun 04, 2024 4:14pm

246 Views

Post# 36071901

Someone tell me the odds are not in our favor.

Problem: Pyridox (am) ine 5'-phosphate oxidase (PNPO) deficiency is an inborn error of vitamin B6 metabolism, which causes an epileptic fit

Cure: MC-1 is an investigational drug that contains pyridoxal 5'-phosphate monohydrate (PLP), a naturally occurring metabolite of pyridoxine (vitamin B6). https://www.medicure.com/epilepsy

<< Previous

Bullboard Posts

Next >>

Here are three global stocks you should watch